Insider Buying: Adtalem Global Education (NYSE:CVSA) Director Acquires 8,890 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) Director Michael Malafronte purchased 8,890 shares of Adtalem Global Education stock in a transaction dated Wednesday, March 11th. The shares were bought at an average cost of $100.94 per share, for a total transaction of $897,356.60. Following the transaction, the director directly owned 25,395 shares of the company’s stock, valued at approximately $2,563,371.30. The trade was a 53.86% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Adtalem Global Education Stock Down 0.2%

Adtalem Global Education stock traded down $0.20 during midday trading on Thursday, hitting $100.90. The stock had a trading volume of 43,310 shares, compared to its average volume of 434,531. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26. The firm has a market cap of $3.48 billion, a P/E ratio of 14.82, a P/E/G ratio of 0.85 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Wednesday, January 28th. The company reported $2.43 EPS for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.The company had revenue of $503.39 million during the quarter.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CVSA shares. Barrington Research reaffirmed an “outperform” rating and issued a $170.00 price target on shares of Adtalem Global Education in a report on Monday, March 2nd. Zacks Research raised Adtalem Global Education from a “hold” rating to a “strong-buy” rating in a report on Tuesday, February 24th. Finally, Weiss Ratings assumed coverage on Adtalem Global Education in a report on Wednesday, February 25th. They issued a “hold (c+)” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Adtalem Global Education currently has a consensus rating of “Buy” and a consensus target price of $170.00.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.